文献速递瓣膜外科

经胸骨上入路行经导管主动脉瓣置换术

Transcatheter Aortic Valve Replacement by a Novel Suprasternal Approach.
PubMed 文献 · Ann Thorac Surg · 2018-02-15

本研究纳入11例经股动脉入路不适合的严重主动脉瓣狭窄患者,采用胸骨上入路行经导管主动脉瓣置换术,并与经主动脉、经心尖、经锁骨下入路患者进行倾向性匹配比较。结果显示胸骨上及经锁骨下入路患者术后下地活动更早、住院时间更短,且不增加并发症。

要点

  • 胸骨上入路经导管主动脉瓣置换术可用于经股动脉入路不适合的患者。
  • 胸骨上及经锁骨下入路患者术后下地活动时间早于经主动脉入路。
  • 胸骨上及经锁骨下入路患者住院时间短于经主动脉或经心尖入路。

核心结论

  • 胸骨上及经锁骨下入路与其他非股动脉经导管主动脉瓣置换入路相比,下地活动更早、住院时间更短,且不增加并发症。
  • 原文指出需进一步研究以确定胸骨上入路是否为股动脉血管条件差的经导管主动脉瓣置换患者的首选替代入路。

研究设计与样本

  • 研究纳入11例经股动脉入路不适合并接受胸骨上入路经导管主动脉瓣置换术的患者。
  • 采用倾向性匹配法将胸骨上入路患者与经主动脉、经心尖、经锁骨下入路经导管主动脉瓣置换术患者进行比较。

主要发现

  • 11例胸骨上入路患者中,6例(54.5%)使用自膨胀瓣膜装置,5例(45.5%)使用球囊扩张瓣膜。
  • 术后下地活动中位时间:胸骨上入路1.6天(四分位距0.9至1.8),经锁骨下入路1.6天(四分位距0.9至2.7),经主动脉入路3.9天(四分位距1.9至4.5),p=0.001。
  • 住院时间中位数:胸骨上入路4天(四分位距3至8),经锁骨下入路4天(四分位距4至8),经主动脉入路8天(四分位距6至14),经心尖入路6天(四分位距7至11),p=0.01。
  • 原文结论指出胸骨上及经锁骨下入路不增加并发症。

局限性

  • 原文结论指出需进一步研究以确定胸骨上入路是否为股动脉血管条件差的经导管主动脉瓣置换患者的首选替代入路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcatheter aortic valve replacement (TAVR) provides therapy for patients with severe aortic stenosis at extreme, high, or intermediate surgical risk. Transfemoral access has been the preferred access route; however, this approach is not suitable for many TAVR candidates. A suprasternal approach may allow for earlier ambulation and shorter hospital stay as compared with other, nontransfemoral approaches. METHODS: A total of 11 patients with unsuitable transfemoral access underwent suprasternal TAVR. Propensity matching was used to compare suprasternal patients to patients undergoing transaortic, transapical, and trans-subclavian TAVR. RESULTS: Groups were well matched for baseline characteristics. A self-expanding valve device was used in 6 (54.5%) and a balloon-expandable valve in 5 (45.5%) of the 11 patients treated by the suprasternal route. Suprasternal and trans-subclavian patients were able to ambulate earlier than patients treated by the transaortic route, a median 1.6 days (interquartile range [IQR]: 0.9 to 1.8), 1.6 days (IQR: 0.9 to 2.7), and 3.9 days (IQR: 1.9 to 4.5) after the procedure for suprasternal, trans-subclavian, and transaortic patients, respectively (p = 0.001). Length of hospitalization was shorter for patients treated by suprasternal or trans-subclavian access in comparison with patients treated by the transaortic or transapical approach: median 4 days (IQR: 3 to 8) and 4 days (IQR: 4 to 8) versus 8 days (IQR: 6 to 14) and 6 days (IQR: 7 to 11) for suprasternal and trans-subclavian versus transaortic and transapical, respectively (p = 0.01). CONCLUSIONS: Suprasternal and trans-subclavian access are associated with earlier ambulation and shorter hospitalization than other nontransfemoral TAVR routes, without an increase in complications. Further study is required to determine if suprasternal is the alternative access of choice for TAVR patients with poor transfemoral vasculature.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Codner P, Pugliese D, Kouz R, et al. Transcatheter Aortic Valve Replacement by a Novel Suprasternal Approach. Ann Thorac Surg. 2018. PMID: 29397928. doi:10.1016/j.athoracsur.2017.10.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。